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ABSTRACT Acetyl coenzyme A (acetyl-CoA) carboxylase (ACCase) plays a central role in carbonmetabolism and has been the site
of action for the development of therapeutics or herbicides, as its product, malonyl-CoA, is a precursor for production of fatty
acids and other compounds. Control of Acc1 activity in the yeast Saccharomyces cerevisiae occurs mainly at two levels, i.e., regu-
lation of transcription and repression by Snf1 protein kinase at the protein level. Here, we demonstrate a strategy for improving
the activity of ACCase in S. cerevisiae by abolishing posttranslational regulation of Acc1 via site-directed mutagenesis. It was
found that introduction of two site mutations in Acc1, Ser659 and Ser1157, resulted in an enhanced activity of Acc1 and in-
creased total fatty acid content. As Snf1 regulation of Acc1 is particularly active under glucose-limited conditions, we evaluated
the effect of the two site mutations in chemostat cultures. Finally, we showed that our modifications of Acc1 could enhance the
supply of malonyl-CoA and therefore successfully increase the production of two industrially important products derived from
malonyl-CoA, fatty acid ethyl esters and 3-hydroxypropionic acid.
IMPORTANCE ACCase is responsible for carboxylation of acetyl-CoA to produce malonyl-CoA, which is a crucial step in the con-
trol of fatty acid metabolism. ACCase opened the door for pharmaceutical treatments of obesity and diabetes as well as the devel-
opment of new herbicides. ACCase is also recognized as a promising target for developing cell factories, as its malonyl-CoA
product serves as a universal precursor for a variety of high-value compounds in white biotechnology. Yeast ACCase is a good
model in understanding the enzyme’s catalysis, regulation, and inhibition. The present study describes the importance of pro-
tein phosphorylation in regulation of yeast ACCase and identifies potential regulation sites. This study led to the generation of a
more efficient ACCase, which was applied in the production of two high-value compounds derived frommalonyl-CoA, i.e., fatty
acid ethyl esters that can be used as biodiesel and 3-hydroxypropionic acid that is considered an important platform chemical.
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Acetyl coenzyme A (acetyl-CoA) carboxylase (ACCase; EC6.4.1.2), recognized as an essential enzyme in most living or-
ganisms, is responsible for the carboxylation of acetyl-CoA to
form malonyl-CoA. ACCase is a multisubunit enzyme in pro-
karyotes, whereas it is a single, multidomain enzyme in eu-
karyotes. Although the structures are different between pro- and
eukaryotic species, the reaction mechanisms are essentially the
same in all types of cells (1).
ACCase plays a critical role in regulating fatty acidmetabolism,
as the enzyme catalyzes the first committed and rate-limiting step
in fatty acid biosynthesis, representing an attractive target for
therapeutic intervention in the control of obesity and the treat-
ment of metabolic syndrome (2), in addition to being the site for
development of new herbicides (1). Besides being an essential
component for de novo fatty acid synthesis required for cell growth
(1, 3, 4), malonyl-CoA serves as a major building block for a vari-
ety of relevant compounds in industrial biotechnology (Fig. 1),
such as polyketides and flavonoids (5, 6) or fatty acid-derived
products (7, 8). However, it has been shown that the intracellular
malonyl-CoA concentration is tightly regulated to be very low,
resulting in limited production of malonyl-CoA-derived com-
pounds (5–7, 9).
The transfer of malonyl-CoA-dependent pathways into heter-
ologous hosts or their overexpression in native hosts for various
applications relies on the availability of malonyl-CoA. Metabolic
engineering applications of ACCase have been focused on thema-
nipulation of enzyme levels through gene amplification. The first
example was overexpression of a set of four Escherichia coli sub-
unit proteins of ACCase in a coordinated manner, which resulted
in a nearly 50-fold increased activity of the enzyme and a 6-fold
increase in the rate of free fatty acid synthesis in E. coli (10). This
was proven to be an effective approach for fatty acid production in
additional studies, where a set of E. coli ACCase genes was (over)
expressed in cyanobacteria (11) and E. coli (7, 9). This strategy also
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allows the development of engineered strains for enhanced pro-
duction of various fatty acid-derived products (12). In another
study, introduction ofCorynebacterium glutamicumACCase, con-
sisting of only two subunits, into E. coli led to an increase of the
cellular malonyl-CoA concentration by 3-fold and improved
malonyl-CoA-derived phloroglucinol production (5). Similarly,
related to an increased availability of malonyl-CoA, it was ob-
served that expression of the ACCase genes fromC. glutamicum or
Photorhabdus luminescens in E. coli could lead to increased pro-
duction of flavonones, which are direct precursors of flavonoids
(13, 14). It was also reported that overexpression of ACCase in
Streptomyces coelicolor resulted in an improved polyketide pro-
duction (15). Changing the promoter of ACC1 to the strong con-
stitutive TEF1 promoter in Saccharomyces cerevisiae has been seen
to increase the production of 6-methylsalicylic acid by about 60%
(6). Although many examples of ACCase overexpression were
shown to be suitable for production of a variety of malonyl-CoA-
derived products, these are still limited by the inherent low capac-
ity of the enzyme itself and in particular its tight posttranslational
regulation. Several other attempts to utilize overexpression of AC-
Case in various systems were not satisfactory (5, 8, 16), and there
remains a need to increase ACCase enzyme activity by modifying
its native regulation.
Microbial systems are increasingly being developed as produc-
tion platforms for a wide variety of chemicals and biofuels to de-
crease the dependency on fossil resources. These target chemicals
and biofuels are frequently produced by incorporating heterolo-
gous or modifying endogenous metabolic pathways in well-
characterized host microorganisms, such as E. coli or S. cerevisiae.
Nowadays, the yeast S. cerevisiae is often preferred as the host for
the development of a new process due to its robustness and toler-
ance toward different environmental conditions, an extensive
technology platform available for this organism, well-studied ge-
netics, and a long history of industrial use with a well-established
reputation (17, 18). There are therefore many examples that illus-
trate the suitability of this cell factory for the production of a range
of fuels (16–18) and chemicals (17–19). In addition, to reduce the
production costs, many efforts have been reported to make
S. cerevisiae efficiently grow on and metabolize pentoses that are
present in hemicelluloses (20–23). Following decades of continu-
ous efforts, S. cerevisiae is likely to become a key cell factory plat-
form in the future (17, 18).
In S. cerevisiae, cytosolic ACCase is encoded by ACC1 and mi-
tochondrial ACCase by HFA1. To eliminate issues with transport
across the mitochondrial membranes, it is desirable to assemble
heterologous biosynthetic pathways in the cytosol for most bio-
technological projects. Therefore, it is of great interest to under-
stand the regulation of Acc1 activity. ACC1 is transcriptionally
regulated in coordination with phospholipid biosynthesis by pos-
itive (Ino2p and Ino4p) and negative (Opi1p) regulatory factors
(4). Since it belongs to a family of biotin-dependent carboxylases,
the efficiency of Acc1 biotinylation controls its activity at the pro-
tein level, and it has been reported that reduced levels of this vita-
min affect the synthesis of fatty acids (24). Protein phosphoryla-
tion is one of the most important posttranslational modifications
and plays a key role in signal transduction and gene regulation. It
has been suggested that phosphorylation by Snf1 inactivates puri-
fied Acc1 (25, 26) (Fig. 1), and mutants lacking Snf1 display in-
creased Acc1 activity (3, 25). Except for the regulation of Acc1,
Snf1 is also responsible for the induction of genes involved in
gluconeogenesis, glyoxylate cycle, and-oxidation of fatty acids as
well as involved in the general stress response, pseudohyphal
growth, aging, and ion homeostasis (27). Therefore, Snf1 could
not be simply deleted for enhancing Acc1 activity. Concerning
phosphorylation of Acc1, one site at Ser1157 was verified by phos-
phoproteome analysis (28). However, it remains to be shown
whether this serine (Ser) residue is the actual target site of Snf1-
mediated phosphorylation. According to the phosphorylation
recognition motif (Hyd-X-Arg-XX-Ser-XXX-Hyd) for Snf1 (29),
besides Ser1157, an additional putative phosphorylation site was
found at Ser659 of Acc1. There are no experimental data on phos-
phorylation of Ser659 reported so far. In this work, we intended to
characterize these proposed phosphorylation sites of Acc1 via site-
directed mutagenesis and evaluate the resultant mutant enzyme
activities.
Modulation of Acc1 activity would directly affect the cellular
concentration of the product malonyl-CoA, and, here, we dem-
onstrate that engineering the protein at the posttranslational level
can increase the enzyme activity of Acc1 and thereby enable im-
proved flux through malonyl-CoA-dependent metabolic path-
ways for the production of chemicals and biofuels, e.g., (i)
3-hydroxypropionic acid (3-HP), a platform chemical that can be
used in synthesis of a variety of chemical derivatives, such as acry-
lates andmalonic acid (30), and (ii) fatty acid ethyl esters (FAEEs)
that can be used as a main constituent of biodiesel used in trucks,
buses, and trains (31).
RESULTS
Site-directedmutagenesis ofAcc1 increases enzymeactivity and
total fatty acid content. Ser1157 of Acc1 has been reported to be a
site of phosphorylation (28), and using the phosphorylation rec-
ognitionmotif (Hyd-X-Arg-XX-Ser-XXX-Hyd) for Snf1 to search
for additional possible phosphorylation sites, we identified Ser659
as a putative site besides Ser1157. These two possible phosphory-
lation sites of Acc1 were mutated from Ser to Ala (see details in
Fig. S1 in the supplemental material). Thus, three versions of
ACC1 were constructed by PCR: (i) wild-type ACC1 (ACC1wt),
FIG 1 Malonyl-CoA works as a major building block. The primary fate of
malonyl-CoA is to serve as a precursor for lipids. However, a wide range of
industrially interesting fuels and chemicals are derived from malonyl-CoA. A
cell factorywith enhanced supply ofmalonyl-CoA could serve as a platform for
malonyl-CoA-derived products. Acc1 is a critical enzyme for malonyl-CoA
synthesis, and the global regulator Snf1 is involved in regulation of Acc1 at the
posttranslational level.
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(ii) ACC1 with one site mutation at Ser1157 (ACC1ser1157ala), and
(iii) ACC1 with two site mutations at Ser1157 and Ser659
(ACC1ser659ala,ser1157ala).
To evaluate the effect of the point mutations on the ACCase
activity, ACC1wt, ACC1ser1157ala, and ACC1ser659ala,ser1157ala were
cloned into multicopy plasmid pSP-GM2 (32) and then trans-
formed into S. cerevisiae CEN.PK 113-5 D to construct the strains
CAW,CAS, andCAD(Table 1), respectively. CB0holds the empty
plasmid pSP-GM2 and was used as a control. ACCase activities in
all strains were determined in stationary phase (Table 2). Overex-
pression of both wild-type and point-mutated ACC1 enhanced
the ACCase activity compared to that of control strain CB0.
In strain CAW, which harbors ACC1wt on plasmid, ACCase activ-
ity was increased by 20%. While the enzyme activity was 80%
higher in the single-mutated version of ACC1 (ACC1ser1157ala) in
strain CAS than for the control strain, overexpression of
ACC1ser659ala,ser1157ala resulted in a 3-fold increase of ACCase ac-
tivity, which was the highest increase.
Overexpression of wild-type or point-mutated Acc1 clearly led
to an increase in the enzyme activity and thereby supposedly in-
creased the formation of malonyl-CoA, a crucial precursor for
fatty acid biosynthesis. Therefore, we also measured the concen-
tration of total fatty acids in strains CB0, CAW, CAS, and CAD
(Table 2). We found no significant increase in the total fatty acid
content when overexpressing ACC1wt compared with that of the
control strain. Overexpression of ACC1ser1157ala, however, re-
sulted in a 14 0.2% improvement in the total fatty acid content,
and overexpression of ACC1ser659ala,ser1157ala resulted in a 65 
0.3% increase in the total fatty acid content (strain CAD).
Characterization of different Acc1 versions in the absence of
SNF1. The effect of increased activity of Acc1 shown in Table 2
could be explained by the introduced site mutations, Ser659 and
Ser1157, which are suggested to function as phosphorylation sites
recognized by Snf1 protein kinase (29). To evaluate this further,
we expressed the two mutated enzymes as well as the wild-type
form of the enzyme in an snf1 strain.
SNF1was deleted in strain CEN.PK 113-5D, resulting in strain
SC00. Empty plasmid and plasmids holding three different ver-
sions of ACC1 were introduced into SC00, resulting in strains
SC01, SC02, SC03, and SC04 (Table 1). These strains were cul-
tured in glucose-limited chemostat cultures (growth rate at
0.1 h1), where Snf1 is normally active, and analyzed for their
ACCase activity. No apparent physiological difference was found
in chemostat cultures when different versions of Acc1 were over-
TABLE 1 List of strains used in this study
Strain Genotype or relevant characteristics
Gene overexpressed by plasmid
Source or referencepSP-GM2 pIYC04
CEN.PK 113-5 D MATa MAL2-8c SUC2 ura3-52 NAa NA P. Kötterc
CEN.PK 506-1 C MATa URA3 HIS3 TRP1 LEU2 SUC2 MAL2-8C snf1
(4-1899)::loxP-kanMX-loxP
NA NA P. Kötter
SC00 MATa MAL2-8c SUC2 ura3-52 snf1::loxP-kanMX-loxP NA NA This study
SC01 SC00 Emptyb NA This study
SC02 SC00 ACC1wt NA This study
SC03 SC00 ACC1ser1157ala NA This study
SC04 SC00 ACC1ser659ala,ser1157ala NA This study
CB0 CEN.PK 113-5D Empty NA 16
CAW CEN.PK 113-5D ACC1wt NA This study
CAS CEN.PK 113-5D ACC1ser1157ala NA This study
CAD CEN.PK 113-5D ACC1ser659ala,ser1157ala NA This study
CEN.PK 113-11 C MATa his3-1 ura3-52 MAL2-8c SUC2 NA NA P. Kötter
CB2H1 CEN.PK 113-11 C Empty ws2 This study
CB2H2 CEN.PK 113-11 C ACC1wt ws2 This study
CB2H3 CEN.PK 113-11 C ACC1ser1157ala ws2 This study
CB2H4 CEN.PK 113-11 C ACC1ser659ala,ser1157ala ws2 This study
HPY15 CEN.PK 113-11 C Empty mcrCa This study
HPY16 CEN.PK 113-11 C ACC1wt mcrCa This study
HPY17 CEN.PK 113-11 C ACC1ser1157ala mcrCa This study
HPY18 CEN.PK 113-11 C ACC1ser659ala,ser1157ala mcrCa This study
a NA, strain was not transformed with any plasmid.
b Empty, strain was transformed with empty plasmid.
c University of Frankfurt, Germany.
TABLE 2 Activities of acetyl coenzyme A carboxylase and total fatty acid content in strains holding different versions of ACC1a
Strain Total fatty acid content (% of CDW) ACCase activity (pmol/min/mg of cell-free protein extract)
CB0 7.1 1.5 24 3
CAW 7.4 1.5 29 3
CAS 8.1 1.5 43 4
CAD 11.7 2.0 74 9
a CB0, control strain with empty plasmid; CAW, strain with overexpressed ACC1wt; CAS, strain with overexpressed ACC1ser1157ala; CAD, strain with overexpressed
ACC1ser659ala,ser1157ala. The total fatty acid contents are expressed as percentages of dry-weight biomass. Strains were sampled at stationary phase. The reported results are the
averages from three replicate experiments standard deviations.
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expressed. Compared to the higher enzyme activity for the mu-
tated versions of Acc1 in the presence of SNF1 (Table 2), all the
strains with overexpression of different versions of ACC1, i.e.,
strains SC02, SC03, and SC04, had similar ACCase activities in the
absence of SNF1 (Table 3). These results clearly indicate that
Ser1157 and Ser659 play a role in regulation of Acc1 activity, most
likely as phosphorylation target sites of Snf1.
UsingmutatedAcc1 forproductionofmalonyl-CoA-derived
products. From the above-given information, it is clear that site-
directedmutagenesis ofACC1 results in increased activity, leading
to higher total lipid content (Table 2), indicating increased supply
ofmalonyl-CoA.We therefore wanted to evaluate if this phenom-
enon could be applied for improving the production of malonyl-
CoA-derived products, of which FAEEs and 3-HP were taken as
examples (see Fig. 2).
FAEEs can be produced by yeast following the introduction of
a heterologous wax ester synthase gene (ws2), and the supply of
malonyl-CoA has been found to be limiting the production (31).
Therefore, as expected, overexpression of the different mutant
ACC1 genes increased FAEE production (Table 4). Compared to
the FAEE-producing reference strain CB2H1 that holds only the
ws2 gene with an FAEE production of 4.8  0.7 mg/liter, strain
CB2H2 that overexpresses ACC1wt has a slightly increased FAEE
production (around 20%), while strain CB2H3 that overexpresses
ACC1ser659ala showed a much higher increase (around 2-fold).
Furthermore, overexpression of ACC1ser659ala,ser1157ala in strain
CB2H4 resulted in the highest FAEE production, corresponding
to a 3-fold improvement. Some physiological parameters of the
different strains are listed in Table S1 in the supplemental mate-
rial. The strains with higher activity of Acc1 showed a lower
growth rate, and their final biomass concentration was also re-
duced.
A second case study was the production of 3-HP. As shown in
Fig. 2, biosynthesis of 3-HP can be realized directly frommalonyl-
CoA in two reaction steps catalyzed by the multifunctional
malonyl-CoA reductase encoded by the mcrCa gene from Chloro-
flexus aurantiacus, as reported before (33). The production of
3-HP (Table 4) in the different strains showed a trend similar to
FAEE production. In HPY16, where ACC1wt was overexpressed,
3-HP production was improved by 60% compared to HPY15 that
carries only mcrCa. Interestingly, when ACC1ser659ala was overex-
pressed instead of the wild-type gene in HPY17, there was a more
than 2.5-fold improvement in 3-HPproduction over the reference
strain HPY15, and by overexpressing ACC1ser659ala,ser1157ala in
HPY18, an improvement of more than 3.5-fold over HPY15 was
obtained. Some physiological parameters of the different strains
are listed in Table S2 in the supplemental material. A reduction in
growth rate and biomass yield was found when the different ver-
sions of ACC1 were overexpressed. With regard to the accumula-
tion of 3-HP in glucose and ethanol phases (see Table S2), the
similar increasing trend was observed when ACC1wt,
ACC1ser659ala, or ACC1ser659ala,ser1157ala were overexpressed. More
interestingly, it was found that the highest improvements, up to
TABLE 3 Activities of acetyl coenzyme A carboxylase in snf1 deletion
strains holding different versions of ACC1a
Strain Enzyme activity (pmol/min/mg of cell-free protein extract)
SC01 33 8
SC02 57 5
SC03 62 9
SC04 63 6
a SC01, control snf1 deletion strain with empty plasmid; SC02, snf1 deletion strain with
overexpressed ACC1wt; SC03, snf1 deletion strain with overexpressed ACC1ser1157ala;
SC04, snf1 deletion strain with overexpressed ACC1ser659ala,ser1157ala. Samples were
taken from chemostat cultures after a steady state was maintained for about 50 h. The
reported results are the averages from duplicate experiments standard deviations.
FIG 2 Reconstruction of FAEEs and 3-HP biosynthesis in Saccharomyces
cerevisiae. Single and double arrows represent single and multiple enzymatic
steps; dashed arrows represent heterologous pathways. FAEEs, fatty acid ethyl
esters; 3-HP, 3-hydroxypropionic acid.
TABLE 4 Production of FAEEs and 3-HP in different strains holding different versions of ACC1
Strain (Over)expressed genes (HIS3 and URA3)a Total FAEE production (mg/liter) Total 3-HP production (mg/liter)
CB2H1 ws2 and —b 4.7 0.7
CB2H2 ws2 and ACC1wt 5.6 0.8
CB2H3 ws2 and ACC1ser1157ala 9.5 0.9
CB2H4 ws2 and ACC1ser659ala,ser1157ala 15.8 2.5
HPY15 mcrCa and — 82.2 2.2
HPY16 mcrCa and ACC1wt 126.8 5.9
HPY17 mcrCa and ACC1ser1157ala 210.9 9.9
HPY18 mcrCa and ACC1ser659ala,ser1157ala 279 19.8
a Gene (over)expressed in HIS3 and URA3 based plasmid.
b No gene was inserted for (over)expression.
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6-fold (with ACC1ser659ala,ser1157ala) compared to the control, were
in the ethanol phase, where Snf1 is most active.
DISCUSSION
In S. cerevisiae, as well as in other higher eukaryotes, the activity of
ACCase rather than the fatty acid synthetase complex determines
the regulation of fatty acid synthesis (1). Therefore, ACCase is
assumed to be a promising target for the development of thera-
peutics and herbicides and for biotechnology approaches.
Currently, a major challenge in understanding regulation of
yeast Acc1 (encoding cytosolic ACCase) is to define its character-
istics of posttranslational modification through protein phos-
phorylation. We here show that introduction of site mutation at
Ser1157 and/or Ser659 of Acc1 resulted in an increase in Acc1
activity (Table 2), indicating that these two assumed phosphory-
lation sites are highly related to determining the enzyme activity in
vivo. We further demonstrated that there is no difference in activ-
ity of the different mutant enzymes in an SNF1 deletion strain.
Phosphorylation at Ser1157 has been indicated in a previous study
(28). Although no phosphorylation has been seen for Ser659 in
any study so far, it may still occur. Our data strongly indicate that
the introduced mutations were able to relieve Snf1-regulated re-
pression of Acc1. Whether this regulation, presumably through
protein phosphorylation, is directly or indirectlymediated by Snf1
remains to be seen. We also found that there is a 40% increased
activity of ACCase in an snf1 deletion strain compared to that of
the reference strain (Tables 2 and 3), consistent with an earlier
study that suggested a key role of phosphorylation onAcc1 activity
with the evidence thatACC1 expression is reduced in snf1mutants
but still displays higher activity of the enzyme (25). It is also inter-
esting that the deletion of SNF1 in SC01 gives a higher ACCase
activity than elevation of its transcriptional level by overexpres-
sion ofACC1wt on a plasmid in CAW (Tables 2 and 3). From these
results, it is clear that activity of Acc1 is controlled primarily at the
posttranscriptional level. Although there have been a variety of
projects targeted to modulate Acc1 activity, this study is the first
describingmodulation at the posttranslational level. It is observed
that the Acc1 activitymeasured in this study ismuch lower than in
previous reports (34, 35). One possible explanation could be bio-
tin deficiency. However, this would be reflected in a decrease in
C18 fatty acids (24), which is not the case in our strains. The reason
for this difference could also be due to the fact that cell extracts
were used directly for enzyme analysis in this study, and previous
reports had purified the enzyme before enzyme analysis (34, 35).
Differences in media and sampling times may also explain the
differences in enzyme activity.
It is known that fatty acid biosynthesis highly depends on the
activity of Acc1 (1, 3, 7), and here we also found a positive effect of
the enhanced Acc1 activity on the total fatty acid content (Ta-
ble 2), indicating limitations for fatty acid biosynthesis associated
with Acc1 activity. Limitations in malonyl-CoA availability also
impede biotechnological synthesis of many industrially relevant
products.
Here, we demonstrated that expression of our identified more
efficient Acc1 mutants could improve the production of two
malonyl-CoA-derived products, i.e., FAEEs and 3-HP (Table 4).
In both cases, the observed highest improvement was caused by
overexpression of ACC1ser659ala,ser1157ala, and the fold changes
were similar to the improvement in ACCase activity by overex-
pression of this mutant enzyme (Table 2). This points to a signif-
icant flux control at Acc1 for production of both products. An
impaired growth was observed in both cases when strains had an
enhanced activity of Acc1 and their final biomass concentrations
were also reduced, as shown inTables S1 and S2 in the supplemen-
tal material. This is presumably due to an imbalanced synthesis of
long-chain fatty acids or depletion of intermediates. A similar re-
sult has been reported in a previous review, whichmentioned that
overexpression of Acc1 together with Bpl1 (encoding the enzyme
biotin-apoprotein ligase) can even be lethal (4). A harmful effect
on growth caused by overexpression of ACCase was also found in
bacteria (10).
The highest production of FAEEs in CB2H4 reached 15.8 mg/
liter, which is much lower than the value achieved using an engi-
neered E. coli strain (31), but it is comparable with the highest
FAEE production reported for S. cerevisiae from simple sugars,
which is 17.2 mg/liter (36). In the latter study, fatty acid metabo-
lism was heavily modified by eliminating nonessential fatty acid
utilization pathways (36), and it is interesting that here almost the
same titer was reached by simply overexpressing
ACC1ser659ala,ser1157ala. Samples for FAEE measurements were
taken in stationary phase, as yeast cells can accumulate substantial
amounts of lipids during the late exponential and stationary
phases (37), which is also true for FAEE accumulation (see Ta-
ble S1). During this phase, FAEEs were produced and ACCase
would theoretically be inactived by Snf1 (3). In the case of 3-HP,
when overexpressing ACC1ser659ala,ser1157ala, an approximately
6-fold increase was found during the ethanol phase, while only an
approximately 2-fold increase was observed in the glucose phase
compared to that in the control (see Table S2). This is probably
due to the fact that the availability of cytosolic acetyl-CoA is higher
during the ethanol phase than during the glucose phase (19). Still,
the improvements when overexpressing the mutated Acc1 (5- to
6-fold) are greater than the improvementswith thewild-typeAcc1
(2-fold). This difference reflects the efficiency of converting
acetyl-CoA intomalonyl-CoA, indicating again a connectionwith
Snf1-mediated phosphorylation, since the kinase is active mainly
in this phase. These two cases suggest that regulation of this spe-
cific reactionwas not only the result of gene expression but resides
to a large extent in posttranslational modifications, which should
be taken into account for future metabolic engineering strategies.
There are several other examples of enzymes that are regulated
posttranslationally rather than by expression level variation (38–
40). A very good example is the control of yeast central metabo-
lism by enzyme phosphorylation (40).
Yeast ACCase exhibits strong similarity to the respective en-
zyme sequences of mammals and plants (2). The AMP-activated
protein kinase (AMPK) is responsible for phosphorylation and
inhibition of ACCase in human; in yeast, Acc1 is phosphorylated
by Snf1 (25, 26); Snf1-related protein kinases (SnRKs) play the
regulatory role in higher plants. AMPK, Snf1, and SnRKs all be-
long to the Snf1 protein kinase family (41). The high conservation
of ACCases from yeast to mammals and plants suggests that the
yeast ACCase can be used as a model to study themolecular inter-
actions in human physiology as well as for the development of
targets in disease treatments (42), or it can be used as a guide to
control lipid metabolism in plants for developing high-lipid-
content plants as renewable and sustainable feedstocks for the
production of liquid biofuels (43). Our findings represent a step
forward in achieving these goals.
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Conclusion. ACCase, which is crucial for the anabolism of
malonyl-CoA and fatty acids (1), was also suggested to be the
major rate-controlling step for production of a variety of high-
value compounds derived frommalonyl-CoA. Overexpression of
ACCase has previously been applied in many studies for redirect-
ing flux toward malonyl-CoA (1, 5–7, 9, 10). However, these ap-
proaches are still limited by the inherent low enzyme activity. In
this study, it is interesting to note that a more efficient Acc1 was
obtained by the introduction of two site mutations at Ser1157 and
Ser659, which are suggested to be related to Snf1-mediated phos-
phorylation. The strains with higher activity of Acc1 showed a
notable advantage for the production of malonyl-CoA-derived
products, as demonstrated for the production of FAEEs and 3-HP.
Our new finding is therefore also likely to be applicable for many
other products that are derived from malonyl-CoA. The present
study highlights the importance of engineering proteins along
with metabolic engineering as a key strategy in achieving im-
proved microbial cell factories.
MATERIALS AND METHODS
Strains and plasmids. All DNA manipulations were carried out in E. coli
DH5 as described (44). All constructs have been checked by sequencing.
The plasmids used are derived from pIYC04 (19) and pSP-GM2 (32).
The endogenousACC1 gene (wild type) encoding acetyl-CoA carbox-
ylase was amplified from genomic DNA of CEN.PK 113-5D by PCR with
Phusion high-fidelity polymerase (Thermo Scientific, Waltham, MA,
USA). The primers are listed inTable S3 in the supplementalmaterial. The
ACC1ser1157ala single-point mutation and ACC1ser659ala,ser1157ala double-
point mutation were introduced by oligonucleotide primers (details are
shown in Fig. S1). Three versions of ACC1 were digested with NotI and
SacI and then ligated into the corresponding sites of pSP-GM2 and con-
trolled by constitutive PGK1 promoter.
For FAEE production in S. cerevisiae, the codon-optimized wax syn-
thase gene (ws2) fromMarinobacter hydrocarbonoclasticusDSM 8798 was
adopted from a former study (16). The ws2 gene was ligated into pIYC04
under control of theTEF1 promoter. For 3-HPproduction in S. cerevisiae,
the gene mcrCa encoding malonyl-CoA reductase from Chloroflexus au-
rantiacuswas codon optimized based on the codon preference of S. cerevi-
siae (GenScript, Piscataway, NJ, USA). The mcrCa gene was ligated into
pIYC04 downstream of the TEF1 promoter.
S. cerevisiae strains used in this work are listed in Table 1. All experi-
ments were performed in the background of CEN.PK (45, 46). Yeast
transformation was conducted using the standard LiAc/SS carrier DNA/
PEG method (47). SNF1 was deleted in S. cerevisiae CEN.PK 113-5 D to
construct strain SC00 using a fragment containing the kanMX marker
flanked by SNF1 up- and downstream regions amplified from genomic
DNA of CEN.PK 506-1 C [MATa URA3 HIS3 TRP1 LEU2 SUC2
MAL2–8C snf1 (4-1899)::loxP-kanMX-loxP] (48) by PCR, with the fol-
lowing oligonucleotides: SNF1-UP and SNF1-DOWN (see Table S3). The
strains with SNF1 deletion were selected from yeast extract-peptone-
dextrose (YPD) plates containing G418 (0.2 mg/ml) and verified by PCR.
Plasmids were transformed into the corresponding host strains for con-
struction of new strains (Table 1). Successful mutants were picked from
synthetic dextrose (SD) agar plates with the appropriate medium compo-
sition (36).
Growth conditions. Strains were grown on SD agar plates containing
the appropriate medium composition for selection.
For enzyme activity and total fatty acid analysis, strains of S. cerevisiae
were cultured in synthetic medium (19) with 20 g/liter glucose in shake
flasks. The culture volume in the shake flasks was 20 ml with an initial
optical density at 600 nm (OD600) of 0.02 after inoculation from precul-
tures grown overnight in synthetic medium.
For FAEE and 3-HP production, strains of S. cerevisiae were cultured
in syntheticmedium (19)with 20 g/liter glucose in 1.0-literDasgip stirrer-
pro bioreactors (Dasgip, Jülich, Germany). The working volume was
0.6 liters, and the cultivation was carried out at an agitation of 600 rpm,
with an aeration rate of 1 vvm (gas volume flow per unit of liquid volume
per minute), a pH of 5, and using 2MKOH and a controlled temperature
of 30°C. The initial OD600 of the cultures was around 0.02 after inocula-
tion from precultures.
Chemostat cultivation. Chemostat cultures were carried out in 1.0-
liter Dasgip stirrer-pro bioreactors with a 0.6-liter working volume under
aerobic conditions using a dilution rate of 0.10 (0.005) h1. The pHwas
maintained at 5.0 with 2 M KOH, with a controlled temperature at 30°C,
an airflow rate at 1 vvm, and agitation at 600 rpm. The emission of CO2
and residual O2 was monitored by Dasgip fedbatch pro gas analysis sys-
tems, equipped with off-gas analyzer GA4 based on zirconium dioxide
and a two-beam infrared sensor (Dasgip). Strains were grown in synthetic
medium containing (per liter) 10 g of glucose, 5 g of (NH4)2SO4, 3 g of
KH2PO4, 0.5 g of MgSO4 · 7H 2O, 1 ml of vitamin solution, 1 ml of trace
metal solution, and 50ml of Antiform 204 (27). Samples were taken from
the cultures after a steady state wasmaintained for about 50 h. Steady state
refers to cultures without detectable oscillations in values of pH, volume,
and CO2 and O2 in the off-gas and biomass concentrations.
Analytical methods. The growth was measured by optical density at
600 nm and cell dry weight (CDW). CDW was determined by filtering
5 ml of the cell culture through a 0.45-m-pore-size nitrocellulose filter
(Sartorius Stedim, Göttingen, Germany) and measuring the increased
weight of the dry filter. The concentrations of residual glucose and exter-
nal metabolites were analyzed using a Dionex Ultimate 3000 high-
performance liquid chromatography (HPLC) system (Dionex Softron
GmbH, Germering, Germany) with an Aminex HPX-87H column (Bio-
Rad, California) using 5 mMH2SO4 as the mobile phase (16).
Lipid extraction and analysis. Cells were harvested from a volume of
50 ml, washed twice with distilled water, and centrifuged at 3,000 g for
5 min at 4°C. These samples were then frozen at80°C and freeze-dried
for about 3 days or until they appeared dry. Dried cells were weighed
before extraction of lipids and FAEEs. Themethod for lipid extraction and
separation was described previously (16). The analysis was performed in
an ISQ single quadrupole GC-MS (Thermo, Fisher Scientific, Austin, TX)
adopting the previously reported method for fatty acid methyl ester
(FAME) or FAEE analysis (16, 49). FAME or FAEE peaks were identified
using their spectrum patterns compared to their corresponding standard
mix. The standard FAME mix consisted of methyl esters of myristic,
palmitic, palmitoleic, heptadecanoic (internal standard), stearic, oleic,
and arachidic acids (Sigma-Aldrich, St. Louis, LA, USA), and the standard
FAEE mix consisted of ethyl esters of lauric, myristic, palmitic, palmito-
leic, heptadecanoic (internal standard), stearic, and oleic acids (Cayman
Chemical, Ann Arbor, MI, USA). The serial dilutions in hexane of FAME
or FAEEmix standards were injected to generate standard curves for their
quantification performed with the help of the QuanBrowser function in
the Xcalibur software version 2.0 (Thermo Scientific).
Determination of 3-HP. The concentrations of 3-HP were deter-
mined by HPLC using the previously described method (33). Culture
samples were centrifuged at 12,000 g for 10 min, and the supernatants
were filtered through a 0.20-m-pore-size nitrocellulose filter (Sartorius
Stedim) and analyzed by a Summit HPLC (Dionex, Sunnyvale, CA, USA)
with an Aminex HPX-87H column (Bio-Rad, Hercules) at 65°C using
0.5 mM H2SO4 as the mobile phase at a flow rate of 0.5 ml min1.
Enzyme activity assay.Cell-free extracts were prepared using a previ-
ously reported fast preparation method for enzyme analysis (16). Protein
concentrations weremeasured according to the Bradfordmethod. Acetyl-
CoA carboxylase activities in the extracts were measured in vitro by mon-
itoring the incorporation of labeled carbon from NaH14 CO3 into acid-
stable reaction material as reported previously (50). ACCase activity was
expressed as pmol of 14C incorporated into acid-stable products per min-
ute per milligram of cell-free protein extract.
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